
Expectations for pharmacists related to drug utilization reviews lead to examination of woman's death.
Expectations for pharmacists related to drug utilization reviews lead to examination of woman's death.
Widespread COVID-19 booster shot administration is pending FDA approval and recommendation by the Advisory Committee on Immunization Practices.
New roles and responsibilities can be passed to pharmacy technicians in order to free up pharmacists’ time, which enables them to be more engaged with their patients and provide more direct patient care.
What many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.
Amesh Adalja, MD, FIDSA, FACP, FACEP, said that the efficacy of COVID-19 booster vaccines against variants of concern is still relatively unknown, although administering the third shots does increase antibodies as expected.
Ten quiz questions to assess your knowledge on common dyslipidemia treatments.
Non-alcoholic steatohepatitis is the most severe form of non-alcoholic fatty liver disease.
Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.
COVID-19 vaccination opportunities will likely be present for years to come.
The FDA has approved Qelbree (viloxazine extended-release capsules; Supernus Pharmaceuticals, Inc) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in pediatric patients aged 6 to 17 years.
Alembic Pharmaceuticals, Inc in Bridgewater, NJ is a subsidiary of Alembic Pharmaceuticals Ltd., the oldest pharmaceutical company in India, employing more than 12,000 people.
This has caused an ongoing problem with mistrust in many vaccines and medications, since there is still uncertainty surrounding how they affect other races and ethnicities.
An announcement from CDC officials recommending COVID-19 boosters for all adults could come as soon as this week, although doses would only be widely administered once the FDA formally approved the vaccines.
Physicians may ask for either or both of comprehensive metabolic panel or complete blood count tests every 3 to 6 months, based on the conditions patients have.
Savings for these medications range from 40% to 75.8%, study results show.
Ticovac is the only FDA-approved vaccine against the TBE virus for individuals visiting or living in TBE endemic areas.
It is time to standardize to a single formulation to avoid mix-ups that can lead to adverse effects.
The expanded indication follows Lyumjev’s original approval in 2020 and offers an important new delivery mechanism for patients with diabetes.
Experts anticipate a return to high influenza rates as COVID-19 prevention measures decline.
Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, addresses how the role of pharmacists, opportunities, and issues facing community pharmacies internationally compare to the experience of community pharmacists in the United States.
The amount of green space surrounding children’s homes may impact the development of ADHD.
HDHPs require patients to pay for all care out of pocket until the plan’s deductible is reached, and only after this threshold does insurance start to cover medical costs.
Vitamin D promotes calcium absorption in the gut and maintains adequate serum calcium and phosphate concentrations to enable normal bone mineralization and to prevent hypocalcemic tetany.
Anyone, even young people, can get infected, so the varicella or zoster vaccines offer the best prevention.
The FDA recently authorized COVID-19 vaccine booster shots for immunocompromised individuals, who comprise about 3% of the US population.
Nicholas Mathews, co-founder of Stillwater Behavioral Health, discusses how pharmacists can respond to the identification of potentially problematic opioid prescription practices at sober-living facilities.
Analyzing how off-target antibodies may be undermining HIV vaccine prototypes allows for design improvements.
Trial is the first to suggest that targeting interleukin-4 and interleukin-13 can help address symptoms such as persistent itching and hives.